| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.095 | 0.1 |